Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China 2020-11-23 18:32
Huami Corporation Reports Third Quarter 2020 Unaudited Financial Results 2020-11-23 17:10
Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA™ Viral MagBead Kit 2020-11-23 14:05
Picosun's medical ALD solutions enable safer surgeries 2020-11-23 10:54
Rewardz Empowers Employees with Joye - A Mental Wellness & Self-Care Offering 2020-11-23 10:00
ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC 2020-11-23 09:30
CGTN: China calls for more inclusive development in post-COVID world 2020-11-23 09:09
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies 2020-11-23 09:00
Infinitus Harnesses eCommerce to Offer Greater Direct Selling Opportunities for Partners 2020-11-23 09:00
G20 Riyadh Summit: Release of Leaders' Declaration 2020-11-23 08:30
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020 2020-11-23 08:00
Firestorm Fire Protection PTY Announces Rebranding, Changes Name to United Safety 2020-11-23 07:00
Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease 2020-11-20 23:07
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange 2020-11-20 21:09
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease 2020-11-20 21:00
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting 2020-11-20 21:00
Ortho's CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals 2020-11-20 20:00
CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December 2020-11-20 19:00
Successful Day 1 of COMEUP 2020, with more than 50,000 accumulative online views, 7,500 pre-registrations, and 400,000 accumulative visits to the homepage 2020-11-20 18:10
Concord Medical Schedules 2020 Annual Meeting of Shareholders 2020-11-20 17:00
1 596 597 598 599 600 1502